CompletedNot applicableNCT04875949

Anti-Cholinergic Receptors Antibodies, Autonomic Profile and Dysautonomia Symptoms in PAF, ALS and POTS (DISAUT-AB)

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Istituto Clinico Humanitas
Principal Investigator
Raffaello Furlan, Prof.
Humanitas Research Hospital, Humanitas University
Intervention
Immunoabsorption/plasmapheresis procedure(procedure)
Enrollment
75 enrolled
Eligibility
18 years · All sexes
Timeline
2016 – 2019

Study locations (1)

Collaborators

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Fondazione Salvatore Maugeri

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04875949 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis →

← Back to all trials